Arixtra (fondaparinux) vs. lovenox (enoxaparin) in prevention of deep vein thrombosis in acute medically ill, non-surgical patients.
Phase of Trial: Phase II
Latest Information Update: 08 Dec 2017
At a glance
- Drugs Enoxaparin sodium (Primary) ; Fondaparinux sodium (Primary)
- Indications Deep vein thrombosis
- Focus Adverse reactions
- Acronyms BRiEF
- 08 Jul 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 13 Dec 2007 Status changed from initiated to recruiting.
- 03 Sep 2007 New trial record.